Zosano Pharma Corporation
Oct 07, 2019
A New Era for Migraine Treatment and CGRP antibodies
The World Health Organization’s disability rating for migraine ranks it as the 19th most common reason for disability. According to the Migraine Trust Organization, Migraine is ranked as the 7th most disabling disease in the world (a cause for a loss of 2.9% of all years of life lost to disability/YLDs). The ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
